Back to Search Start Over

Selective Neck Dissection and Survival in Pathologically Node-Positive Oral Squamous Cell Carcinoma

Authors :
Shunichi Shimura
Jun-ichi Kobayashi
Takeshi Kaneko
Tadashi Hasegawa
Shota Shimizu
Tomohiro Igarashi
Kazuhiro Ogi
Akihiro Miyazaki
Hiroyoshi Hiratsuka
Tomoko Sonoda
Akira Miyakawa
Source :
Cancers, Cancers, Vol 11, Iss 2, p 269 (2019), Volume 11, Issue 2
Publication Year :
2019
Publisher :
MDPI AG, 2019.

Abstract

The most important prognostic factor in oral squamous cell carcinoma (OSCC) is neck metastasis, which is treated by neck dissection. Although selective neck dissection (SND) is a useful tool for clinically node-negative OSCC, its efficacy for neck node-positive OSCC has not been established. Sixty-eight OSCC patients with pN1&ndash<br />3 disease who were treated with curative surgery using SND and/or modified-radical/radical neck dissection (MRND/RND) were retrospectively reviewed. The neck control rate was 94% for pN1&ndash<br />3 patients who underwent SND. The five-year overall survival (OS) and disease-specific survival (DSS) in pN1-3 OSCC patients were 62% and 71%, respectively. The multivariate analysis of clinical and pathological variables identified the number of positive nodes as an independent predictor of SND outcome (OS, hazard ratio (HR) = 4.98, 95% confidence interval (CI): 1.48&ndash<br />16.72, p &lt<br />0.01<br />DSS, HR = 6.44, 95% CI: 1.76&ndash<br />23.50, p &lt<br />0.01). The results of this retrospective study showed that only SND for neck node-positive OSCC was appropriate for those with up to 2 lymph nodes that had a largest diameter &le<br />3 cm without extranodal extension (ENE) of the neck and adjuvant radiotherapy. However, the availability of postoperative therapeutic options for high-risk OSCC, including ENE and/or multiple positive lymph nodes, needs to be further investigated.

Details

ISSN :
20726694
Volume :
11
Database :
OpenAIRE
Journal :
Cancers
Accession number :
edsair.doi.dedup.....484c23ed31cd0d0968c1f0638f39eb9b
Full Text :
https://doi.org/10.3390/cancers11020269